Skip to main content

Nasdaq IPOs

Checkmate Pharmaceuticals prices IPO at $15 midpoint

6 years 2 months ago
Checkmate Pharmaceuticals, a clinical stage immuno-oncology biotech developing therapies for solid tumors, raised $75 million by offering 5 million shares at $15, within the range of $14 to $16. Checkmate Pharmaceuticals plans to list on the Nasdaq under the symbol CMPI. BofA Sec
Renaissance Capital

Considering Minority-Owned Firms for Your IPO

6 years 2 months ago
Minority-owned firms (or diversity and inclusion firms) have played a growing role in initial public offerings (IPOs) in recent years, most notably with branded consumer companies with anticipated market capitalizations greater than $1 billion.
Jonathan Schaffer

Medical device maker Acutus Medical prices upsized IPO at $18 high end

6 years 2 months ago
Acutus Medical, which manufactures devices for electrophysiological mapping to treat arrhythmias, raised $159 million by offering 8.8 million shares at $18, the high end of the range of $16 to $18. The company offered 1.5 million more shares than anticipated. Certain existing sha
Renaissance Capital

Rocket Companies prices downsized IPO at $18, below the range

6 years 2 months ago
Rocket Companies, a leading mortgage lender operating under the Rocket and Quicken brands, raised $1.8 billion by offering 100 million shares at $18, below the range of $20 to $22. The company had originally planned to sell 150 million shares. Rocket Companies plans to list on th
Renaissance Capital

Israeli pain relief biotech PainReform sets terms for $23 million IPO

6 years 2 months ago
PainReform, a Phase 2 Israeli biotech developing therapies for post-operative pain relief, announced terms for its IPO on Wednesday. The Herzliya, Israel-based company plans to raise $23 million by offering 2.6 million shares at a price range of $8 to $10. At the midpoint of the
Renaissance Capital

Diversified retail REIT NetSTREIT sets terms for $310 million IPO

6 years 2 months ago
NetSTREIT, a net lease REIT that manages single-tenant retail commercial properties, announced terms for its IPO on Wednesday. The Dallas, TX-based company plans to raise $310 million by offering 15.5 million shares (2% insider) at a price range of $19 to $21. At the midpoint of
Renaissance Capital
Checked
22 minutes 48 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed